These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18603221)

  • 1. Efficacy and clinical safety of ramelteon: an evidence-based review.
    Sateia MJ; Kirby-Long P; Taylor JL
    Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ramelteon for the treatment of insomnia.
    Borja NL; Daniel KL
    Clin Ther; 2006 Oct; 28(10):1540-55. PubMed ID: 17157111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ; Wang-Weigand S; Zhang J
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN; Elliott E; Nelson LA
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
    Roth T; Seiden D; Sainati S; Wang-Weigand S; Zhang J; Zee P
    Sleep Med; 2006 Jun; 7(4):312-8. PubMed ID: 16709464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of ramelteon in a first-night model of transient insomnia.
    Zammit G; Schwartz H; Roth T; Wang-Weigand S; Sainati S; Zhang J
    Sleep Med; 2009 Jan; 10(1):55-9. PubMed ID: 18691937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A novel therapeutic drug: ramelteon].
    Miyamoto M
    Nihon Rinsho; 2009 Aug; 67(8):1595-600. PubMed ID: 19768947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ramelteon: a novel treatment for the treatment of insomnia.
    Wurtman R
    Expert Rev Neurother; 2006 Jul; 6(7):957-64. PubMed ID: 16831111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
    Erman M; Seiden D; Zammit G; Sainati S; Zhang J
    Sleep Med; 2006 Jan; 7(1):17-24. PubMed ID: 16309958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramelteon: profile of a new sleep-promoting medication.
    Owen RT
    Drugs Today (Barc); 2006 Apr; 42(4):255-63. PubMed ID: 16703122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term exposure to ramelteon, a melatonin receptor agonist, on endocrine function in adults with chronic insomnia.
    Richardson G; Wang-Weigand S
    Hum Psychopharmacol; 2009 Mar; 24(2):103-11. PubMed ID: 19090503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of ramelteon in Japanese adults with chronic insomnia: a randomized, double-blind, placebo-controlled study.
    Uchimura N; Ogawa A; Hamamura M; Hashimoto T; Nagata H; Uchiyama M
    Expert Rev Neurother; 2011 Feb; 11(2):215-24. PubMed ID: 21306209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a post-sleep questionnaire-interactive voice response system (PSQ-IVRS) to evaluate the subjective sleep effects of ramelteon in adults with chronic insomnia.
    Wang-Weigand S; Watissée M; Roth T
    Sleep Med; 2011 Oct; 12(9):920-3. PubMed ID: 21925941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ramelteon: a review of its therapeutic potential in sleep disorders.
    Pandi-Perumal SR; Srinivasan V; Spence DW; Moscovitch A; Hardeland R; Brown GM; Cardinali DP
    Adv Ther; 2009 Jun; 26(6):613-26. PubMed ID: 19568703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute sleep-promoting action of the melatonin agonist, ramelteon, in the rat.
    Fisher SP; Davidson K; Kulla A; Sugden D
    J Pineal Res; 2008 Sep; 45(2):125-32. PubMed ID: 18298466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
    Mini L; Wang-Weigand S; Zhang J
    Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
    Barkin RL
    Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia.
    Karim A; Tolbert D; Cao C
    J Clin Pharmacol; 2006 Feb; 46(2):140-8. PubMed ID: 16432265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
    Najib J
    Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.